ea0029p823 | Endocrine tumours and neoplasia | ICEECE2012
Toaiari M.
, Davi M.
, Boninsegna L.
, Falconi M.
, Francia G.
Introduction: In 2009 the Endocrine Societys clinical practice guidelines for management of hypoglycemic disorders, confirming previous suggestions, have stated that the new cut-off of insulin for the diagnosis of insulinoma should be lowed to 3 μU/mL in presence of hypoglycemia (serum glucose ≤55 mg/dL). Moreover hypoglycemia in post-prandial status has been reported in insulinoma, alone or associated with fasting hypoglycemia. Finally preexisting diabetes me...